This document, the COVID-19 National Deployment and Vaccination Plan (NDVP) for South Sudan, has been written and is being presented by a working group of vaccination and public health specialists representing the South Sudan Ministry of Health (Directorate General Primary Health Care, EPI Services and COVID-19 National Steering Committee) the World Health Organization South Sudan Country Office, UNICEF South Sudan Country Office, the Health Pooled Fund (HPF) South Sudan and John Snow Inc (JSI) South Sudan. This group of experts have been collaborating since October 2020 through to the present in:
the process of ongoing assessing and preparing the level of readiness for the introduction of one or more COVID-19 vaccines, initially resulting in the deployment of AstraZeneca Covishield vaccine in late March 2021,
the development of operational plans and the associated budgets for implementing the vaccination programme in all ten States and 35 of the 80 Counties, from April through July 2020.
During this vaccination period, referred to as Phase I in this revised NDVP, 57,150 doses of Covishield vaccine were administered (95% of the 60,000 available doses),
revising the NDVP in line with amendments to the implementation of the COVID-19 vaccination programme. Such amendments to the operational plan by the COVID-19 Technical Team follow having carried out a comprehensive review of the budgetary requirements for Phase II of vaccinations, received Ministry of Health approval for vaccine administration to involve non-nurse experienced vaccinators who are integral to the routine immunisation activities in-country as well as the Technical Team having extensively discussed and documented best practices and challenges from Phase I in a COVID-19 vaccination Intra-Action Review (IAR).
Based on the aforementioned points, please receive the updated South Sudan COVID-19 NDVP that is being submitted for kind perusal and valuable feedback.